Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors

Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors

Saved in:

Bibliographic Details
Main Authors:	Toshio Shimizu, John Powderly, Albiruni Abdul Razak, Patricia LoRusso, Kathy D. Miller, Steven Kao, Sarah Kongpachith, Catherine Tribouley, Michelle Graham, Brian Stoll, Maulik Patel, Mohammad Sahtout, Martha Blaney, Rachel Leibman, Talia Golan, Anthony Tolcher
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Oncology
Subjects:	advanced solid tumors TGF-ß1 GARP immunotherapy anti-PD-1 antibody combination drug therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1544394/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors
by: Toshio Shimizu, et al.
Published: (2024-10-01)

Garp Linyitleri İşletmesi (GLİ) Şlam Kömürlerinin Spiral ile Zenginleştirilebilirliğine Tane Boyutunun Etkisi
by: Ali Uçar, et al.
Published: (2021-06-01)

Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
by: Doron Yablecovitch, et al.
Published: (2024-09-01)

AÇIĞA ÇIKARILAN TERCİHLER: TEORİ VE UYGULAMA
by: Haydar Akyazı, et al.
Published: (2021-11-01)

A bioinformatics approach for identifying the probable cause of the cross-interaction of antibodies to the antigenic protein HPV16 L1 with the HPV6 L1 protein
by: A. S. Stolbikov, et al.
Published: (2021-12-01)

Anti-LGI1 antibody autoimmune encephalitis. Clinical case presentation and literature review
by: A. Stašaitytė, et al.
Published: (2021-03-01)

Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
by: A. N. Chikaev, et al.
Published: (2021-09-01)

Monoclonal antibody development and antigenic epitope identification of chicken pro-IL-1β
by: Mengmeng Xu, et al.
Published: (2025-02-01)

Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies
by: Yizhou Zhang, et al.
Published: (2024-12-01)

Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
by: Mingya Cao, et al.
Published: (2025-01-01)

Caerin 1.1/1.9-mediated antitumor immunity depends on IFNAR-Stat1 signalling of tumour infiltrating macrophage by autocrine IFNα and is enhanced by CD47 blockade
by: Junjie Li, et al.
Published: (2025-01-01)

Maternal F1 antibodies and cytokines in mother-neonate dog pairs in the Marmota himalayana plague focus
by: Deming Tang, et al.
Published: (2025-02-01)

Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer
by: Rui Xu, et al.
Published: (2025-01-01)

AdipoR1 enhances the radiation resistance via ESR1/CCNB1IP1/cyclin B1 pathway in hepatocellular carcinoma cells
by: Yuhan Gan, et al.
Published: (2025-01-01)

CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibody
by: Cristina Melero, et al.
Published: (2024-12-01)

Establishment of a Rapid and Convenient Fluoroimmunoassay Platform Using Antibodies Against PDL1 and HER2
by: Ji Eun Choi, et al.
Published: (2025-01-01)

Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1
by: Pauline Malinge, et al.
Published: (2024-12-01)

AKT1-Mediated NOTCH1 phosphorylation promotes gastric cancer progression via targeted regulation of IRS-1 transcription
by: Lingshan Zhou, et al.
Published: (2024-12-01)

Faith, hope and love - a missionary perspective on three seminal motifs in 1 Thessalonians 1:3
by: P. G. R. de Villiers
Published: (2003-06-01)

Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapy
by: Kun Du, et al.
Published: (2025-02-01)

IDENTIFICATION OF A (1B)1R SUBSTITUTION AND 1BL.1RS TRANSLOCATION IN WINTER WHEAT INTROGRESSION LINES BY CYTOGENETIC AND MOLECULAR METHODS
by: I. I. Motsnyy, et al.
Published: (2014-12-01)

Cuba vs H1N1 Influenza
by: Gail Reed
Published: (2011-04-01)

Structure- and machine learning-guided engineering demonstrate that a non-canonical disulfide in an anti-PD-1 rabbit antibody does not impede antibody developability
by: Wei-Ching Liang, et al.
Published: (2024-12-01)

Screening of West Siberian patients with primary congenital glaucoma for CYP1B1 gene mutations
by: D. E. Ivanoshchuk, et al.
Published: (2020-12-01)

Computational design of drug candidates for influenza A virus subtype H1N1 by inhibiting the viral neuraminidase-1 enzyme
by: Tambunan Usman Sumo Friend, et al.
Published: (2014-06-01)

Phosphatidylinositol promoted the proliferation and invasion of pituitary adenoma cells by regulating POU1F1 expression
by: Tongjiang Xu, et al.
Published: (2025-01-01)

Influenza A (H1N1) Pneumonia. Three cases in children.
by: Ariel Efrén Uriarte Méndez, et al.
Published: (2011-04-01)

SIRT1/PGC-1α-mediated mitophagy participates the improvement roles of BMAL1 in podocytes injury in diabetic nephropathy: evidences from in vitro experiments
by: Yanxia Rui, et al.
Published: (2025-01-01)

Polymeric Multivalent Fc Binding Peptides‐Fabricated Clinical Compounding Bispecific Antibody Potentiates Dual Immunotherapy Targeting PD1 and CTLA‐4
by: Zongyu Liu, et al.
Published: (2025-01-01)

1q21.1 Duplication Syndrome and Anorectal Malformations: A Literature Review and a New Case
by: Maria Minelli, et al.
Published: (2025-01-01)

A humanized anti-MSLN×4-1BB bispecific antibody exhibits potent antitumour activity through 4-1BB signaling activation and fc function without systemic toxicity
by: Da-yan Zhang, et al.
Published: (2025-01-01)

Proclaiming the gospel in Macedonia, Achaia and in every place. Missions and 1 Thessalonians 1:6-8
by: P. G. R. de Villiers
Published: (2003-12-01)

The impact of SLCO1B1 polymorphisms on homocysteine concentrations: evidence for a stronger association in men
by: Xinyuan Hu, et al.
Published: (2025-01-01)

Integrative analysis of single-cell and transcriptome sequencing with experimental validation reveals PKHD1L1 as a novel biomarker in lung adenocarcinoma
by: Xiangqian Zhang, et al.
Published: (2025-01-01)

Effects of GS-CA1 on nuclear envelope-associated early HIV-1 infection steps
by: Amita Singh, et al.
Published: (2025-02-01)

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
by: Danyi Ao, et al.
Published: (2023-04-01)

Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiency
by: Fabiola Del Carpio-Cano, et al.
Published: (2025-01-01)

L1 spaces fail a certain aapproximative property
by: Aref Kamal
Published: (1998-01-01)

ENO1 promotes PDAC progression by inhibiting CD8+ T cell infiltration through upregulating PD-L1 expression via HIF-1α signaling
by: Aziguli Tulamaiti, et al.
Published: (2025-02-01)

The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
by: Jing Zhang, et al.
Published: (2025-01-01)